Please provide your email address to receive an email when new articles are posted on . Patients with Crohn’s disease and overweight or obesity who used GLP-1s appeared less likely to become steroid ...

Patients who lose a significant amount of weight with the use of anti-obesity medications after hip or knee replacement showed a significantly reduced risk of requiring a revision surgery compared ...

Obesity was associated with lower odds of steroid-free clinical remission in patients with inflammatory bowel disease (IBD) at week 24 after the initiation of treatment. "In clinical practice, it is ...

While corticosteroid injections can be very effective at alleviating the pain and inflammation of osteoarthritis, they might ...

This retrospective analysis examines employees with obesity and reports on glucagon-like peptide-1 receptor agonist use, comorbidities, and work outcomes over time. Objectives: Obesity has a US ...